Condition: Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis · Sponsor: CSL Behring
This is a phase 2, multicenter, randomized, placebo-controlled, double-blind, parallel-group, proof-of-concept study to assess vamifeport in adult participants with homeostatic iron regulator gene-related hereditary hemochromatosis (HFE-HH). The primary objective of the study is to assess the effect of vamifeport treatment on magnetic resonance imaging (MRI)-based liver iron concentration (LIC) in adult participants with HFE-HH.
This description comes directly from the study's public registry record.
Trial Registration Coordinator · +16108784697 · clinicaltrials@cslbehring.com
Always discuss trial participation with your own doctor first.
| Banner MD Anderson | Gilbert, Arizona, United States | Not Yet Recruiting |
| Infinity Clinical Trials | San Diego, California, United States | Not Yet Recruiting |
| Medical Oncology Associates of San Diego | San Diego, California, United States | Not Yet Recruiting |
| Green Leaf Clinical Trials | Jacksonville, Florida, United States | Recruiting |
| Indiana University Health University Hospital | Indianapolis, Indiana, United States | Recruiting |
| Ochsner Medical Complex - High Grove | Baton Rouge, Louisiana, United States | Recruiting |
| Johns Hopkins University School of Medicine | Baltimore, Maryland, United States | Not Yet Recruiting |
| American Oncology Partners, PA dba The Center for Cancer and Blood Disorders | Bethesda, Maryland, United States | Recruiting |
| James M. Stockman Cancer Institute | Frederick, Maryland, United States | Recruiting |
| University of Michigan Health System (UMHS) | Ann Arbor, Michigan, United States | Not Yet Recruiting |
| Aspirus St. Luke's Clinic - Duluth - Oncology & Hematology | Duluth, Minnesota, United States | Recruiting |
| Hunterdon Hematology Oncology, LLC | Flemington, New Jersey, United States | Not Yet Recruiting |
+ 87 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07332091